Skip to main content
Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging 6/2015

01.05.2015 | Original Article

Visual and statistical analysis of 18F-FDG PET in primary progressive aphasia

verfasst von: Jordi A. Matías-Guiu, María Nieves Cabrera-Martín, María Jesús Pérez-Castejón, Teresa Moreno-Ramos, Cristina Rodríguez-Rey, Rocío García-Ramos, Aida Ortega-Candil, Marta Fernandez-Matarrubia, Celia Oreja-Guevara, Jorge Matías-Guiu, José Luis Carreras

Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging | Ausgabe 6/2015

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Diagnosing progressive primary aphasia (PPA) and its variants is of great clinical importance, and fluorodeoxyglucose (FDG) positron emission tomography (PET) may be a useful diagnostic technique. The purpose of this study was to evaluate interobserver variability in the interpretation of FDG PET images in PPA as well as the diagnostic sensitivity and specificity of the technique. We also aimed to compare visual and statistical analyses of these images.

Methods

There were 10 raters who analysed 44 FDG PET scans from 33 PPA patients and 11 controls. Five raters analysed the images visually, while the other five used maps created using Statistical Parametric Mapping software. Two spatial normalization procedures were performed: global mean normalization and cerebellar normalization. Clinical diagnosis was considered the gold standard.

Results

Inter-rater concordance was moderate for visual analysis (Fleiss’ kappa 0.568) and substantial for statistical analysis (kappa 0.756–0.881). Agreement was good for all three variants of PPA except for the nonfluent/agrammatic variant studied with visual analysis. The sensitivity and specificity of each rater’s diagnosis of PPA was high, averaging 87.8 and 89.9 % for visual analysis and 96.9 and 90.9 % for statistical analysis using global mean normalization, respectively. In cerebellar normalization, sensitivity was 88.9 % and specificity 100 %.

Conclusion

FDG PET demonstrated high diagnostic accuracy for the diagnosis of PPA and its variants. Inter-rater concordance was higher for statistical analysis, especially for the nonfluent/agrammatic variant. These data support the use of FDG PET to evaluate patients with PPA and show that statistical analysis methods are particularly useful for identifying the nonfluent/agrammatic variant of PPA.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Mesulam MM. Primary progressive aphasia and the language network: the 2013 H. Houston Merrit Lecture. Neurology 2013;81:456–62.CrossRefPubMed Mesulam MM. Primary progressive aphasia and the language network: the 2013 H. Houston Merrit Lecture. Neurology 2013;81:456–62.CrossRefPubMed
2.
Zurück zum Zitat Matías-Guiu JA, García-Ramos R. Primary progressive aphasia: from syndrome to disease. Neurologia 2013;28:366–74.CrossRefPubMed Matías-Guiu JA, García-Ramos R. Primary progressive aphasia: from syndrome to disease. Neurologia 2013;28:366–74.CrossRefPubMed
3.
Zurück zum Zitat Gorno-Tempini ML, Hillis AE, Weintraub S, Kertesz A, Mendez M, Cappa SF, et al. Classification of primary progressive aphasia and its variants. Neurology 2011;76:1006–14.CrossRefPubMedCentralPubMed Gorno-Tempini ML, Hillis AE, Weintraub S, Kertesz A, Mendez M, Cappa SF, et al. Classification of primary progressive aphasia and its variants. Neurology 2011;76:1006–14.CrossRefPubMedCentralPubMed
4.
Zurück zum Zitat Herholz K, Carter SF, Jones M. Positron emission tomography imaging in dementia. Br J Radiol 2007;80(2):S160–7.CrossRefPubMed Herholz K, Carter SF, Jones M. Positron emission tomography imaging in dementia. Br J Radiol 2007;80(2):S160–7.CrossRefPubMed
5.
Zurück zum Zitat Bohnen NI, Djang DSW, Herholz K, Anzai Y, Minoshima S. Effectiveness and safety of 18F-FDG PET in the evaluation of dementia: a review of the recent literature. J Nucl Med 2012;53:59–71.CrossRefPubMed Bohnen NI, Djang DSW, Herholz K, Anzai Y, Minoshima S. Effectiveness and safety of 18F-FDG PET in the evaluation of dementia: a review of the recent literature. J Nucl Med 2012;53:59–71.CrossRefPubMed
6.
7.
Zurück zum Zitat Gorno-Tempini ML, Dronkers NF, Rankin KP, Ogar JM, Phengrasamy L, Rosen HJ, et al. Cognition and anatomy in three variants of primary progressive aphasia. Ann Neurol 2004;55:335–56.CrossRefPubMedCentralPubMed Gorno-Tempini ML, Dronkers NF, Rankin KP, Ogar JM, Phengrasamy L, Rosen HJ, et al. Cognition and anatomy in three variants of primary progressive aphasia. Ann Neurol 2004;55:335–56.CrossRefPubMedCentralPubMed
8.
Zurück zum Zitat Josephs KA, Duffy JR, Fosset TR, Strand EA, Claassen DO, Whitewell JL, et al. Fluorodeoxyglucose F18 positron emission tomography in progressive apraxia of speech and primary progressive aphasia. Arch Neurol 2010;67:596–605.CrossRefPubMed Josephs KA, Duffy JR, Fosset TR, Strand EA, Claassen DO, Whitewell JL, et al. Fluorodeoxyglucose F18 positron emission tomography in progressive apraxia of speech and primary progressive aphasia. Arch Neurol 2010;67:596–605.CrossRefPubMed
9.
Zurück zum Zitat Clark DG, Charuvastra A, Miller BL, Shapira JS, Mendez MF. Fluent versus nonfluent primary progressive aphasia: a comparison of clinical and functional neuroimaging features. Brain Lang 2005;94:54–60.CrossRefPubMed Clark DG, Charuvastra A, Miller BL, Shapira JS, Mendez MF. Fluent versus nonfluent primary progressive aphasia: a comparison of clinical and functional neuroimaging features. Brain Lang 2005;94:54–60.CrossRefPubMed
10.
Zurück zum Zitat Perneczky R, Diehl-Schmid J, Pohl C, Drzezga A, Kurz A. Non-fluent progressive aphasia: cerebral metabolic patterns and brain reserve. Brain Res 2007;1133:178–85.CrossRefPubMed Perneczky R, Diehl-Schmid J, Pohl C, Drzezga A, Kurz A. Non-fluent progressive aphasia: cerebral metabolic patterns and brain reserve. Brain Res 2007;1133:178–85.CrossRefPubMed
11.
Zurück zum Zitat Rabinovici GD, Jagust WJ, Furst AJ, Ogar JM, Racine CA, Mormino EC, et al. Abeta amyloid and glucose metabolism in the three variants of primary progressive aphasia. Ann Neurol 2008;64:388–401.CrossRefPubMedCentralPubMed Rabinovici GD, Jagust WJ, Furst AJ, Ogar JM, Racine CA, Mormino EC, et al. Abeta amyloid and glucose metabolism in the three variants of primary progressive aphasia. Ann Neurol 2008;64:388–401.CrossRefPubMedCentralPubMed
12.
Zurück zum Zitat Panegyres PK, McCarthy M, Campbell A, Lenzo N, Fallon M, Thompson J. Correlative studies of structural and functional imaging in primary progressive aphasia. Am J Alzheimers Dis Other Demen 2008;23:184–91.CrossRefPubMed Panegyres PK, McCarthy M, Campbell A, Lenzo N, Fallon M, Thompson J. Correlative studies of structural and functional imaging in primary progressive aphasia. Am J Alzheimers Dis Other Demen 2008;23:184–91.CrossRefPubMed
13.
Zurück zum Zitat Rogalski E, Cobia D, Harrison TM, Wieneke C, Weintraub S, Mesulam MM. Progression of language decline and cortical atrophy in subtypes of primary progressive aphasia. Neurology 2011;76:1804–10.CrossRefPubMedCentralPubMed Rogalski E, Cobia D, Harrison TM, Wieneke C, Weintraub S, Mesulam MM. Progression of language decline and cortical atrophy in subtypes of primary progressive aphasia. Neurology 2011;76:1804–10.CrossRefPubMedCentralPubMed
14.
Zurück zum Zitat Lehman VT, Carter RE, Claasen DO, Murphy RC, Lowe V, Petersen RC, et al. Visual assessment versus quantitative three-dimensional sterotactic surface projection fluorodeoxyglucose positron emission tomography for detection of mild cognitive impairment and Alzheimer disease. Clin Nucl Med 2012;37:721–6.CrossRefPubMed Lehman VT, Carter RE, Claasen DO, Murphy RC, Lowe V, Petersen RC, et al. Visual assessment versus quantitative three-dimensional sterotactic surface projection fluorodeoxyglucose positron emission tomography for detection of mild cognitive impairment and Alzheimer disease. Clin Nucl Med 2012;37:721–6.CrossRefPubMed
15.
Zurück zum Zitat Yamame T, Ikari Y, Nishio T, Ishii K, Ishii K, Kato T, et al. Visual-statistical interpretation of (18)F-FDG-PET images for characteristic Alzheimer patterns in a multicenter study: inter-rater concordance and relationship to automated quantitative evaluation. AJNR Am J Neuroradiol 2014;35:244–9.CrossRef Yamame T, Ikari Y, Nishio T, Ishii K, Ishii K, Kato T, et al. Visual-statistical interpretation of (18)F-FDG-PET images for characteristic Alzheimer patterns in a multicenter study: inter-rater concordance and relationship to automated quantitative evaluation. AJNR Am J Neuroradiol 2014;35:244–9.CrossRef
16.
Zurück zum Zitat Ng S, Villemagne VL, Berlangieri S, Lee ST, Cherk M, Gong SJ, et al. Visual assessment versus quantitative assessment of 11C-PIB PET and 18F-FDG PET for detection of Alzheimer’s disease. J Nucl Med 2007;48:547–52.CrossRefPubMed Ng S, Villemagne VL, Berlangieri S, Lee ST, Cherk M, Gong SJ, et al. Visual assessment versus quantitative assessment of 11C-PIB PET and 18F-FDG PET for detection of Alzheimer’s disease. J Nucl Med 2007;48:547–52.CrossRefPubMed
17.
Zurück zum Zitat Arbizu J, Prieto E, Martínez-Lage P, Martí-Climent JM, García-Granero M, Lamet I, et al. Automated analysis of FDG PET as a tool for single-subject probabilistic prediction and detection of Alzheimer’s disease and dementia. Eur J Nucl Med Mol Imaging 2013;40:1394–405.CrossRefPubMed Arbizu J, Prieto E, Martínez-Lage P, Martí-Climent JM, García-Granero M, Lamet I, et al. Automated analysis of FDG PET as a tool for single-subject probabilistic prediction and detection of Alzheimer’s disease and dementia. Eur J Nucl Med Mol Imaging 2013;40:1394–405.CrossRefPubMed
18.
Zurück zum Zitat Eckert T, Barnes A, Dhawan V, Frucht S, Gordon MF, Feigin AS, et al. FDG PET in the differential diagnosis of parkinsonian disorders. Neuroimage 2005;26:912–21.CrossRefPubMed Eckert T, Barnes A, Dhawan V, Frucht S, Gordon MF, Feigin AS, et al. FDG PET in the differential diagnosis of parkinsonian disorders. Neuroimage 2005;26:912–21.CrossRefPubMed
19.
20.
Zurück zum Zitat Dukart J, Mueller K, Horstmann A, Vogt B, Frisch S, Barthel H, et al. Differential effects of global and cerebellar normalization on detection and differentiation of dementia in FDG-PET studies. Neuroimage 2010;49:1490–5.CrossRefPubMed Dukart J, Mueller K, Horstmann A, Vogt B, Frisch S, Barthel H, et al. Differential effects of global and cerebellar normalization on detection and differentiation of dementia in FDG-PET studies. Neuroimage 2010;49:1490–5.CrossRefPubMed
21.
Zurück zum Zitat Tzourio-Mazoyer N, Landeau B, Papathanassiou D, Crivello F, Etard O, Delcroix N, et al. Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. Neuroimage 2002;15:273–89.CrossRefPubMed Tzourio-Mazoyer N, Landeau B, Papathanassiou D, Crivello F, Etard O, Delcroix N, et al. Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. Neuroimage 2002;15:273–89.CrossRefPubMed
22.
Zurück zum Zitat Wicklund MR, Duffy JR, Strand EA, Machulda MM, Whitwell JL, Josephs KA. Quantitative application of the primary progressive aphasia consensus criteria. Neurology 2014;82:1119–26.CrossRefPubMedCentralPubMed Wicklund MR, Duffy JR, Strand EA, Machulda MM, Whitwell JL, Josephs KA. Quantitative application of the primary progressive aphasia consensus criteria. Neurology 2014;82:1119–26.CrossRefPubMedCentralPubMed
23.
Zurück zum Zitat Sajjadi SA, Patterson K, Arnold RJ, Watson PC, Nestor PJ. Primary progressive aphasia: a tale of two syndromes and the rest. Neurology 2012;78:1670–7.CrossRefPubMedCentralPubMed Sajjadi SA, Patterson K, Arnold RJ, Watson PC, Nestor PJ. Primary progressive aphasia: a tale of two syndromes and the rest. Neurology 2012;78:1670–7.CrossRefPubMedCentralPubMed
24.
Zurück zum Zitat Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977;33:159–74.CrossRefPubMed Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977;33:159–74.CrossRefPubMed
25.
Zurück zum Zitat Burdette JH, Minoshima S, Vander Borght T, Tran DD, Kuhl DE. Alzheimer disease: improved visual interpretation of PET images using three-dimensional stereotaxic surface projections. Radiology 1996;198:837–43.CrossRefPubMed Burdette JH, Minoshima S, Vander Borght T, Tran DD, Kuhl DE. Alzheimer disease: improved visual interpretation of PET images using three-dimensional stereotaxic surface projections. Radiology 1996;198:837–43.CrossRefPubMed
26.
Zurück zum Zitat Womack KB, Diaz-Arrastia R, Aizenstein HJ, Arnold SE, Barbas NR, Boeve BF, et al. Temporoparietal hypometabolism in frontotemporal lobar degeneration and associated imaging diagnostic errors. Arch Neurol 2011;68:329–7.CrossRefPubMedCentralPubMed Womack KB, Diaz-Arrastia R, Aizenstein HJ, Arnold SE, Barbas NR, Boeve BF, et al. Temporoparietal hypometabolism in frontotemporal lobar degeneration and associated imaging diagnostic errors. Arch Neurol 2011;68:329–7.CrossRefPubMedCentralPubMed
27.
Zurück zum Zitat Silverman DH. PET in the evaluation of Alzheimer’s disease and related disorders. New York: Springer; 2009.CrossRef Silverman DH. PET in the evaluation of Alzheimer’s disease and related disorders. New York: Springer; 2009.CrossRef
28.
Zurück zum Zitat Le Rhun E, Richard F, Pasquier F. Natural history of primary progressive aphasia. Neurology 2005;65:887–91.CrossRefPubMed Le Rhun E, Richard F, Pasquier F. Natural history of primary progressive aphasia. Neurology 2005;65:887–91.CrossRefPubMed
29.
Zurück zum Zitat Yakushev I, Landvogt C, Buchholz HG, Fellgiebel A, Hammers A, Scheurich A, et al. Choice of reference area in studies of Alzheimer’s disease using positron emission tomography with fluorodeoxyglucose-F18. Psychiatry Res 2008;164:143–53.CrossRefPubMed Yakushev I, Landvogt C, Buchholz HG, Fellgiebel A, Hammers A, Scheurich A, et al. Choice of reference area in studies of Alzheimer’s disease using positron emission tomography with fluorodeoxyglucose-F18. Psychiatry Res 2008;164:143–53.CrossRefPubMed
30.
Zurück zum Zitat Yakushev I, Hammers A, Fellgiebel A, Schmidtmann I, Scheurich A, Buchholz HG, et al. SPM-based count normalization provides excellent discrimination of mild Alzheimer’s disease and amnestic mild cognitive impairment from healthy aging. Neuroimage 2009;44:43–50.CrossRefPubMed Yakushev I, Hammers A, Fellgiebel A, Schmidtmann I, Scheurich A, Buchholz HG, et al. SPM-based count normalization provides excellent discrimination of mild Alzheimer’s disease and amnestic mild cognitive impairment from healthy aging. Neuroimage 2009;44:43–50.CrossRefPubMed
31.
Zurück zum Zitat Dukart J, Perneczky R, Förster S, Barthel H, Diehl-Schmid J, Draganski B, et al. Reference cluster normalization improves detection of frontotemporal lobar degeneration by means of FDG-PET. PLoS One 2013;8:e55415.CrossRefPubMedCentralPubMed Dukart J, Perneczky R, Förster S, Barthel H, Diehl-Schmid J, Draganski B, et al. Reference cluster normalization improves detection of frontotemporal lobar degeneration by means of FDG-PET. PLoS One 2013;8:e55415.CrossRefPubMedCentralPubMed
32.
Zurück zum Zitat Küntzelmann A, Guenther T, Haberkorn U, Essig M, Giesel F, Henze R, et al. Impaired cerebral glucose metabolism in prodromal Alzheimer’s disease differs by regional intensity normalization. Neurosci Lett 2013;534:12–7.CrossRefPubMed Küntzelmann A, Guenther T, Haberkorn U, Essig M, Giesel F, Henze R, et al. Impaired cerebral glucose metabolism in prodromal Alzheimer’s disease differs by regional intensity normalization. Neurosci Lett 2013;534:12–7.CrossRefPubMed
33.
Zurück zum Zitat Perani D, Della Rosa PA, Cerami C, Gallivanone F, Fallanca F, Vanoli EG, et al. Validation of an optimized SPM procedure for FDG-PET in dementia diagnosis in a clinical setting. Neuroimage Clin 2014;6:445–54.CrossRefPubMedCentralPubMed Perani D, Della Rosa PA, Cerami C, Gallivanone F, Fallanca F, Vanoli EG, et al. Validation of an optimized SPM procedure for FDG-PET in dementia diagnosis in a clinical setting. Neuroimage Clin 2014;6:445–54.CrossRefPubMedCentralPubMed
34.
Zurück zum Zitat Rogalski E, Cobia D, Harrison TM, Wieneke C, Weintraub S, Mesulam MM. Progression of language decline and cortical atrophy in subtypes of primary progressive aphasia. Neurology 2011;76:1804–10.CrossRefPubMedCentralPubMed Rogalski E, Cobia D, Harrison TM, Wieneke C, Weintraub S, Mesulam MM. Progression of language decline and cortical atrophy in subtypes of primary progressive aphasia. Neurology 2011;76:1804–10.CrossRefPubMedCentralPubMed
35.
Zurück zum Zitat Matias-Guiu JA, Cabrera-Martín MN, García-Ramos R, Moreno-Ramos T, Valles-Salgado M, Carreras JL, et al. Evaluation of the new consensus criteria for the diagnosis of primary progressive aphasia using fluorodeoxyglucose positron emission tomography. Dement Geriatr Cogn Disord 2014;38:147–52.CrossRefPubMed Matias-Guiu JA, Cabrera-Martín MN, García-Ramos R, Moreno-Ramos T, Valles-Salgado M, Carreras JL, et al. Evaluation of the new consensus criteria for the diagnosis of primary progressive aphasia using fluorodeoxyglucose positron emission tomography. Dement Geriatr Cogn Disord 2014;38:147–52.CrossRefPubMed
Metadaten
Titel
Visual and statistical analysis of 18F-FDG PET in primary progressive aphasia
verfasst von
Jordi A. Matías-Guiu
María Nieves Cabrera-Martín
María Jesús Pérez-Castejón
Teresa Moreno-Ramos
Cristina Rodríguez-Rey
Rocío García-Ramos
Aida Ortega-Candil
Marta Fernandez-Matarrubia
Celia Oreja-Guevara
Jorge Matías-Guiu
José Luis Carreras
Publikationsdatum
01.05.2015
Verlag
Springer Berlin Heidelberg
Erschienen in
European Journal of Nuclear Medicine and Molecular Imaging / Ausgabe 6/2015
Print ISSN: 1619-7070
Elektronische ISSN: 1619-7089
DOI
https://doi.org/10.1007/s00259-015-2994-9

Weitere Artikel der Ausgabe 6/2015

European Journal of Nuclear Medicine and Molecular Imaging 6/2015 Zur Ausgabe